Medicare Enrolled
Dr. Randolph Shey, M.D.
Neurology · Long Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shey
Dr. Randolph Shey is a neurology specialist in Long Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shey performed 2,316 Medicare services across 1,503 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shey received a total of $25,279 from 77 pharmaceutical and/or device companies across 1311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in CA
$25,279 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,316
Medicare services
Top 20% in CA for neurology
1,503
Unique beneficiaries
$117
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~122 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
974 | $102 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
380 | $72 | $121 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
253 | $87 | $150 |
| New patient office visit, complex (60-74 min) | 232 | $171 | $335 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
99 | $349 | $500 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
98 | $77 | $150 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
90 | $118 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $129 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
78 | $151 | $242 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
17 | $188 | $350 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
17 | $252 | $475 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,279
Total received (2018-2024)
Avg $3,611/year across 7 years
Top 13% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
1,311
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,574 (97.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$704 (2.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,823
2023
$4,931
2022
$4,732
2021
$4,114
2020
$1,389
2019
$3,027
2018
$2,262
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$495
UCB, Inc.
$440
Novartis Pharmaceuticals Corporation
$435
ABBVIE INC.
$329
MDD US Operations, LLC
$282
Alexion Pharmaceuticals, Inc.
$267
PFIZER INC.
$210
Amgen Inc.
$178
Biogen, Inc.
$168
Lundbeck LLC
$167
CSL Behring
$142
Celgene Corporation
$141
Averitas Pharma Inc.
$135
Lilly USA, LLC
$117
EMD Serono, Inc.
$105
Otsuka America Pharmaceutical, Inc.
$104
ACADIA Pharmaceuticals Inc
$101
Genentech USA, Inc.
$99
Kyowa Kirin, Inc.
$98
Eisai Inc.
$92
Takeda Pharmaceuticals U.S.A., Inc.
$86
SCILEX PHARMACEUTICALS INC.
$86
Vanda Pharmaceuticals Inc.
$83
SK Life Science, Inc.
$71
MITSUBISHI TANABE PHARMA AMERICA, INC.
$61
Ipsen Biopharmaceuticals, Inc
$60
ARGENX US, INC.
$58
Abbott Laboratories
$55
Merz Pharmaceuticals, LLC
$32
AstraZeneca Pharmaceuticals LP
$32
Amylyx Pharmaceuticals, Inc.
$29
Alnylam Pharmaceuticals Inc.
$27
LivaNova USA, Inc.
$25
Neurelis, Inc.
$13
Top 3 companies account for 28.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,157
UCB, Inc.
$1,774
Neurocrine Biosciences, Inc.
$1,653
Teva Pharmaceuticals USA, Inc.
$1,535
Biogen, Inc.
$1,299
Alexion Pharmaceuticals, Inc.
$1,233
ACADIA Pharmaceuticals Inc
$812
AbbVie Inc.
$783
Amgen Inc.
$777
Lilly USA, LLC
$768
ABBVIE INC.
$754
CSL Behring
$745
EMD Serono, Inc.
$673
PFIZER INC.
$654
US WorldMeds, LLC
$588
MDD US Operations, LLC
$524
GENZYME CORPORATION
$476
Sunovion Pharmaceuticals Inc.
$473
Lundbeck LLC
$468
Genentech USA, Inc.
$413
SK Life Science, Inc.
$402
Kyowa Kirin, Inc.
$395
Celgene Corporation
$376
Alnylam Pharmaceuticals Inc.
$280
Allergan, Inc.
$272
Takeda Pharmaceuticals U.S.A., Inc.
$249
Adamas Pharmaceuticals, Inc.
$245
AstraZeneca Pharmaceuticals LP
$244
Vanda Pharmaceuticals Inc.
$211
Biohaven Pharmaceuticals, Inc.
$210
Biohaven Pharmaceutical Holding Company Ltd.
$203
Sumitomo Pharma America, Inc.
$198
Otsuka America Pharmaceutical, Inc.
$195
Horizon Therapeutics plc
$188
Eisai Inc.
$184
Allergan Inc.
$181
Janssen Pharmaceuticals, Inc
$179
Supernus Pharmaceuticals, Inc.
$173
ARGENX US, INC.
$157
Acorda Therapeutics, Inc
$151
Amylyx Pharmaceuticals, Inc.
$144
Averitas Pharma Inc.
$135
Grifols USA, LLC
$109
MITSUBISHI TANABE PHARMA AMERICA, INC.
$101
Avanir Pharmaceuticals, Inc.
$101
Mallinckrodt Enterprises LLC
$93
SCILEX PHARMACEUTICALS INC.
$86
Neurelis, Inc.
$84
Abbott Laboratories
$83
NOVARTIS PHARMACEUTICALS CORPORATION
$82
Ipsen Biopharmaceuticals, Inc
$78
Upsher-Smith Laboratories LLC
$78
GE HEALTHCARE
$75
Harmony Biosciences LLC
$69
LivaNova USA, Inc.
$66
Greenwich Biosciences, Inc.
$62
UPSHER-SMITH LABORATORIES LLC
$57
Impax Laboratories, Inc.
$53
EISAI INC.
$49
Scilex Pharmaceuticals Inc.
$40
IDORSIA PHARMACEUTICALS US INC
$36
Boston Scientific Corporation
$34
Merz Pharmaceuticals, LLC
$32
Corium, LLC
$29
JAZZ PHARMACEUTICALS INC.
$29
Catalyst Pharmaceuticals, Inc.
$27
Vertical Pharmaceuticals, LLC
$23
NEUROPACE, INC.
$23
CATALYST PHARMACEUTICALS, INC.
$21
AQUESTIVE THERAPEUTICS, INC.
$21
Nevro Corp.
$19
Mallinckrodt Hospital Products Inc.
$18
Medtronic USA, Inc.
$17
LeMaitre Vascular, Inc.
$16
Mylan Pharmaceuticals Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$13
ASSERTIO THERAPEUTICS, Inc.
$12
Top 3 companies account for 22.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANASTOCLIP · ANDEXXA · APOKYN · APTIOM · ARZERRA · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · COMIRNATY · COPAXONE · DUOPA · Dysport · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HETLIOZ · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PAXLOVID · PONVORY · Ponvory · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · RELYVRIO · REXULTI · REYVOW · RNS Neurostimulator Kit · RYTARY · Rebif · Rystiggo · SOLIRIS · SYMPAZAN · Senza · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Wakix · XADAGO · XCOPRI · Xadago · Xeomin · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
624
Per 100K population
6.3
County median income
$87,760
Nearest hospital
MEMORIALCARE LONG BEACH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shey is a clinical cardiology specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shey experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shey performed 974 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shey receive payments from pharmaceutical companies?
Yes. Dr. Shey received a total of $25,279 from 77 companies across 1,311 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shey's costs compare to other neurologists in Long Beach?
Dr. Shey's average Medicare payment per service is $117. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Long Beach
Browse neurologists in Long Beach ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology